Sarissa Capital Management LP Long-Term Concentrated

CIK: 0001577524 · Show all filings

Period: Q4 2024 (← Previous) (Next →)

Filing Date: Feb 14, 2025

Total Value ($000): $322,863 (100.0% shares, 0.0% debt)

Holdings (8)

INVA INNOVIVA INC 39.1%

Value ($000) $126,256 Shares 7,277,000 Est. Cost $13.02 Unrealized +47.5%

IRWD IRONWOOD PHARMACEUTICALS INC 22.5%

Value ($000) $72,608 Shares 16,390,000 Est. Cost $11.52 Unrealized -64.8%

NBIX NEUROCRINE BIOSCIENCES INC 13.1%

Value ($000) $42,194 Shares 309,116 Est. Cost $108.95 Unrealized +13.5%

CYTK CYTOKINETICS INC 12.1%

Value ($000) $39,222 Shares 833,799 Est. Cost $64.95 Unrealized -20.0%

GILD GILEAD SCIENCES INC 7.5%

Value ($000) $24,208 Shares 262,080 Est. Cost $58.12 Unrealized +49.7%

— AMARIN CORP PLC 3.7%

Value ($000) $12,053 Shares 24,850,623 Est. Cost $1.48 Unrealized —

LNTH LANTHEUS HLDGS INC 1.7%

Value ($000) $5,636 Shares 63,000 Est. Cost $100.08 Unrealized -2.7%

— VOR BIOPHARMA INC 0.2%

Value ($000) $686 Shares 618,000 Est. Cost $43.10 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
INVA	INNOVIVA INC	7,277,000	$126,256	39.1%	$13.02	+47.5%	COM	45781M101
IRWD	IRONWOOD PHARMACEUTICALS INC	16,390,000	$72,608	22.5%	$11.52	-64.8%	COM CL A	46333X108
NBIX	NEUROCRINE BIOSCIENCES INC	309,116	$42,194	13.1%	$108.95	+13.5%	COM	64125C109
CYTK	CYTOKINETICS INC	833,799	$39,222	12.1%	$64.95	-20.0%	COM NEW	23282W605
GILD	GILEAD SCIENCES INC	262,080	$24,208	7.5%	$58.12	+49.7%	COM	375558103
—	AMARIN CORP PLC	24,850,623	$12,053	3.7%	$1.48	—	SPONS ADR NEW	023111206
LNTH	LANTHEUS HLDGS INC	63,000	$5,636	1.7%	$100.08	-2.7%	COM	516544103
—	VOR BIOPHARMA INC	618,000	$686	0.2%	$43.10	—	COM	929033108